已收盘 09-03 16:00:00 美东时间
0.000
0.00%
ImmunoPrecise Antibodies (NASDAQ:HYFT) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is unchanged from the same period last year. The company
2025-12-15 21:42
MindWalk Holdings (NASDAQ:HYFT) has authorized a share repurchase program of up to 2.3M common shares. The buyback represents ~5% of the company’s 46.15M shares outstanding. The program will run from ...
2025-10-09 19:41
MindWalk Holdings Corp. reported its financial results for the first fiscal quarter of 2026, ended July 31, 2025. The company achieved record quarterly revenue of $7.6 million, marking a 45% increase ...
2025-09-15 20:44
An Evolution in Name, Structure, and Strategy Reflecting the Company's AI-Driven Platform and Bio-Native Discovery Vision
2025-09-03 20:52
ImmunoPrecise Antibodies Ltd. has announced its rebranding as MindWalk, reflecting its evolution into a Bio-Native AI platform company. The name change underscores a strategic shift towards integratin...
2025-09-03 20:48
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) is set to participate in the 27th Annual H.C. Wainwright Global Investment Conference, occurring from September 8th to 10th, 2025, in New York. Dr. Jennifer...
2025-09-02 20:03
迅雷绩后上演翻倍行情!投资影石创新浮盈超50亿;OpenDoor隔夜大涨19%,此前获知名加密货币投资者买入>>
2025-08-19 19:53
ImmunoPrecise Antibodies (NASDAQ:IPA) announced on Wednesday the successful sale of its Netherlands-based subsidiary, ImmunoPrecise Antibodies to AVS Bio for a total enterprise value of $12M. AVS Bi...
2025-08-06 20:42